Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease

Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD. In a prospectiv...

Full description

Saved in:
Bibliographic Details
Published inGastroenterology (New York, N.Y. 1943) Vol. 162; no. 7; pp. 1990 - 2003
Main Authors Velenosi, Thomas J., Ben-Yakov, Gil, Podszun, Maren C., Hercun, Julian, Etzion, Ohad, Yang, Shanna, Nadal, Cathy, Haynes-Williams, Vanessa, Huang, Wen-Chun A., González-Hódar, Lila, Brychta, Robert J., Takahashi, Shogo, Akkaraju, Vikas, Krausz, Kristopher W., Walter, Mary, Cai, Hongyi, Walter, Peter J., Muniyappa, Ranganath, Chen, Kong Y., Gonzalez, Frank J., Rotman, Yaron
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2022
Subjects
Online AccessGet full text
ISSN0016-5085
1528-0012
1528-0012
DOI10.1053/j.gastro.2022.03.004

Cover

Abstract Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD. In a prospective clinical study, 37 patients with NAFLD and 10 healthy control subjects ingested a standardized liquid meal with pre- and postprandial blood sampling. Postprandial plasma lipid kinetics were characterized at the molecular lipid species level by untargeted lipidomics, cluster analysis, and lipid particle isolation, then confirmed in a mouse model. There was a specific increase of multiple plasma diacylglycerol (DAG) species at 4 hours postprandially in patients with NAFLD but not in controls. This was replicated in a nonalcoholic steatohepatitis mouse model, where postprandial DAGs increased in plasma and concomitantly decreased in the liver. The increase in plasma DAGs appears early in the disease course, is dissociated from NAFLD severity and obesity, and correlates with postprandial insulin levels. Immunocapture isolation of very low density lipoprotein in human samples and stable isotope tracer studies in mice revealed that elevated postprandial plasma DAGs reflect hepatic secretion of endogenous, rather than meal-derived lipids. We identified a selective insulin-related increase in hepatic secretion of endogenously derived DAGs after a mixed meal as a unique feature of NAFLD. DAGs are known to be lipotoxic and associated with atherosclerosis. Although it is still unknown whether the increased exposure to hepatic DAGs contributes to extrahepatic manifestations and cardiovascular risk in NAFLD, our study highlights the importance of extending NAFLD research beyond the fasting state. [Display omitted] In humans with nonalcoholic liver disease and in mouse models of the disease, a mixed meal leads to selective secretion of diacylglycerols from the liver to the plasma through very low density lipoprotein.
AbstractList Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD.BACKGROUND & AIMSHepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD.In a prospective clinical study, 37 patients with NAFLD and 10 healthy control subjects ingested a standardized liquid meal with pre- and postprandial blood sampling. Postprandial plasma lipid kinetics were characterized at the molecular lipid species level by untargeted lipidomics, cluster analysis, and lipid particle isolation, then confirmed in a mouse model.METHODSIn a prospective clinical study, 37 patients with NAFLD and 10 healthy control subjects ingested a standardized liquid meal with pre- and postprandial blood sampling. Postprandial plasma lipid kinetics were characterized at the molecular lipid species level by untargeted lipidomics, cluster analysis, and lipid particle isolation, then confirmed in a mouse model.There was a specific increase of multiple plasma diacylglycerol (DAG) species at 4 hours postprandially in patients with NAFLD but not in controls. This was replicated in a nonalcoholic steatohepatitis mouse model, where postprandial DAGs increased in plasma and concomitantly decreased in the liver. The increase in plasma DAGs appears early in the disease course, is dissociated from NAFLD severity and obesity, and correlates with postprandial insulin levels. Immunocapture isolation of very low density lipoprotein in human samples and stable isotope tracer studies in mice revealed that elevated postprandial plasma DAGs reflect hepatic secretion of endogenous, rather than meal-derived lipids.RESULTSThere was a specific increase of multiple plasma diacylglycerol (DAG) species at 4 hours postprandially in patients with NAFLD but not in controls. This was replicated in a nonalcoholic steatohepatitis mouse model, where postprandial DAGs increased in plasma and concomitantly decreased in the liver. The increase in plasma DAGs appears early in the disease course, is dissociated from NAFLD severity and obesity, and correlates with postprandial insulin levels. Immunocapture isolation of very low density lipoprotein in human samples and stable isotope tracer studies in mice revealed that elevated postprandial plasma DAGs reflect hepatic secretion of endogenous, rather than meal-derived lipids.We identified a selective insulin-related increase in hepatic secretion of endogenously derived DAGs after a mixed meal as a unique feature of NAFLD. DAGs are known to be lipotoxic and associated with atherosclerosis. Although it is still unknown whether the increased exposure to hepatic DAGs contributes to extrahepatic manifestations and cardiovascular risk in NAFLD, our study highlights the importance of extending NAFLD research beyond the fasting state.CONCLUSIONSWe identified a selective insulin-related increase in hepatic secretion of endogenously derived DAGs after a mixed meal as a unique feature of NAFLD. DAGs are known to be lipotoxic and associated with atherosclerosis. Although it is still unknown whether the increased exposure to hepatic DAGs contributes to extrahepatic manifestations and cardiovascular risk in NAFLD, our study highlights the importance of extending NAFLD research beyond the fasting state.
Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD. In a prospective clinical study, 37 patients with NAFLD and 10 healthy control subjects ingested a standardized liquid meal with pre- and postprandial blood sampling. Postprandial plasma lipid kinetics were characterized at the molecular lipid species level by untargeted lipidomics, cluster analysis, and lipid particle isolation, then confirmed in a mouse model. There was a specific increase of multiple plasma diacylglycerol (DAG) species at 4 hours postprandially in patients with NAFLD but not in controls. This was replicated in a nonalcoholic steatohepatitis mouse model, where postprandial DAGs increased in plasma and concomitantly decreased in the liver. The increase in plasma DAGs appears early in the disease course, is dissociated from NAFLD severity and obesity, and correlates with postprandial insulin levels. Immunocapture isolation of very low density lipoprotein in human samples and stable isotope tracer studies in mice revealed that elevated postprandial plasma DAGs reflect hepatic secretion of endogenous, rather than meal-derived lipids. We identified a selective insulin-related increase in hepatic secretion of endogenously derived DAGs after a mixed meal as a unique feature of NAFLD. DAGs are known to be lipotoxic and associated with atherosclerosis. Although it is still unknown whether the increased exposure to hepatic DAGs contributes to extrahepatic manifestations and cardiovascular risk in NAFLD, our study highlights the importance of extending NAFLD research beyond the fasting state.
Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD. In a prospective clinical study, 37 patients with NAFLD and 10 healthy control subjects ingested a standardized liquid meal with pre- and postprandial blood sampling. Postprandial plasma lipid kinetics were characterized at the molecular lipid species level by untargeted lipidomics, cluster analysis, and lipid particle isolation, then confirmed in a mouse model. There was a specific increase of multiple plasma diacylglycerol (DAG) species at 4 hours postprandially in patients with NAFLD but not in controls. This was replicated in a nonalcoholic steatohepatitis mouse model, where postprandial DAGs increased in plasma and concomitantly decreased in the liver. The increase in plasma DAGs appears early in the disease course, is dissociated from NAFLD severity and obesity, and correlates with postprandial insulin levels. Immunocapture isolation of very low density lipoprotein in human samples and stable isotope tracer studies in mice revealed that elevated postprandial plasma DAGs reflect hepatic secretion of endogenous, rather than meal-derived lipids. We identified a selective insulin-related increase in hepatic secretion of endogenously derived DAGs after a mixed meal as a unique feature of NAFLD. DAGs are known to be lipotoxic and associated with atherosclerosis. Although it is still unknown whether the increased exposure to hepatic DAGs contributes to extrahepatic manifestations and cardiovascular risk in NAFLD, our study highlights the importance of extending NAFLD research beyond the fasting state. [Display omitted] In humans with nonalcoholic liver disease and in mouse models of the disease, a mixed meal leads to selective secretion of diacylglycerols from the liver to the plasma through very low density lipoprotein.
Author Walter, Peter J.
Nadal, Cathy
Rotman, Yaron
Cai, Hongyi
Ben-Yakov, Gil
Muniyappa, Ranganath
Brychta, Robert J.
Hercun, Julian
Etzion, Ohad
Yang, Shanna
Walter, Mary
Krausz, Kristopher W.
Gonzalez, Frank J.
Chen, Kong Y.
Takahashi, Shogo
Haynes-Williams, Vanessa
González-Hódar, Lila
Huang, Wen-Chun A.
Velenosi, Thomas J.
Podszun, Maren C.
Akkaraju, Vikas
Author_xml – sequence: 1
  givenname: Thomas J.
  surname: Velenosi
  fullname: Velenosi, Thomas J.
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland
– sequence: 2
  givenname: Gil
  surname: Ben-Yakov
  fullname: Ben-Yakov, Gil
  organization: Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland
– sequence: 3
  givenname: Maren C.
  surname: Podszun
  fullname: Podszun, Maren C.
  organization: Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland
– sequence: 4
  givenname: Julian
  surname: Hercun
  fullname: Hercun, Julian
  organization: Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland
– sequence: 5
  givenname: Ohad
  surname: Etzion
  fullname: Etzion, Ohad
  organization: Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland
– sequence: 6
  givenname: Shanna
  surname: Yang
  fullname: Yang, Shanna
  organization: Nutrition Department, NIH Clinical Center, Bethesda, Maryland
– sequence: 7
  givenname: Cathy
  surname: Nadal
  fullname: Nadal, Cathy
  organization: Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland
– sequence: 8
  givenname: Vanessa
  surname: Haynes-Williams
  fullname: Haynes-Williams, Vanessa
  organization: Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland
– sequence: 9
  givenname: Wen-Chun A.
  surname: Huang
  fullname: Huang, Wen-Chun A.
  organization: Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland
– sequence: 10
  givenname: Lila
  surname: González-Hódar
  fullname: González-Hódar, Lila
  organization: Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland
– sequence: 11
  givenname: Robert J.
  surname: Brychta
  fullname: Brychta, Robert J.
  organization: Diabetes, Endocrinology, and Obesity Branch, NIDDK, NIH, Bethesda, Maryland
– sequence: 12
  givenname: Shogo
  surname: Takahashi
  fullname: Takahashi, Shogo
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland
– sequence: 13
  givenname: Vikas
  surname: Akkaraju
  fullname: Akkaraju, Vikas
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland
– sequence: 14
  givenname: Kristopher W.
  surname: Krausz
  fullname: Krausz, Kristopher W.
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland
– sequence: 15
  givenname: Mary
  surname: Walter
  fullname: Walter, Mary
  organization: Clinical Laboratory Core, NIDDK, NIH, Bethesda, Maryland
– sequence: 16
  givenname: Hongyi
  surname: Cai
  fullname: Cai, Hongyi
  organization: Clinical Mass Spectrometry Core, NIDDK, NIH, Bethesda, Maryland
– sequence: 17
  givenname: Peter J.
  surname: Walter
  fullname: Walter, Peter J.
  organization: Clinical Mass Spectrometry Core, NIDDK, NIH, Bethesda, Maryland
– sequence: 18
  givenname: Ranganath
  surname: Muniyappa
  fullname: Muniyappa, Ranganath
  organization: Diabetes, Endocrinology, and Obesity Branch, NIDDK, NIH, Bethesda, Maryland
– sequence: 19
  givenname: Kong Y.
  surname: Chen
  fullname: Chen, Kong Y.
  organization: Diabetes, Endocrinology, and Obesity Branch, NIDDK, NIH, Bethesda, Maryland
– sequence: 20
  givenname: Frank J.
  surname: Gonzalez
  fullname: Gonzalez, Frank J.
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland
– sequence: 21
  givenname: Yaron
  orcidid: 0000-0002-7549-8216
  surname: Rotman
  fullname: Rotman, Yaron
  email: rotmany@niddk.nih.gov
  organization: Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35283114$$D View this record in MEDLINE/PubMed
BookMark eNqFkV9rFDEUxYNU7Lb6DUTy6MuMN8n8BRFKtVZYtNj6HLLJnZo1M5km2YV586ObZetLX_p0LtzfOVzuOSMnk5-QkLcMSga1-LAt71VMwZccOC9BlADVC7JiNe8KAMZPyCpLU9TQ1afkLMYtAPSiY6_IqciQYKxakb83PqY5qMlY5eiNU3FUdG1na_xodaQ_cY95cTujtoPV9MIlDCpZP1E_0Guc86wLg8Hu0dDPVunF3btFY_AuUjvR735STvvf3mX3lUppyfF7DJmNqCK-Ji8H5SK-edRz8uvqy93ldbH-8fXb5cW6QNHUqei7BqtOtZuuZ9iYqt1wBWwAreq-BcMHjVxA07JuqIdNY8CwFkFpLXRXCcPFOXl_zJ2Df9hhTHK0UaNzakK_i5I3ousrUcMBffeI7jYjGjkHO6qwyP9fy8CnI4D54L3FIKO2OGk0NqBO0ngrGchDTXIrjzXJQ00ShMw15YCPTwK0s5PVyv3B5Xn7P11KnlM
ContentType Journal Article
Copyright 2022
Published by Elsevier Inc.
Copyright_xml – notice: 2022
– notice: Published by Elsevier Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1053/j.gastro.2022.03.004
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1528-0012
EndPage 2003
ExternalDocumentID 35283114
S0016508522002359
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Intramural
GrantInformation_xml – fundername: Canadian Institutes of Health Research
  funderid: https://doi.org/10.13039/501100000024
– fundername: National Institute of Diabetes and Digestive and Kidney Diseases
  funderid: https://doi.org/10.13039/100000062
– fundername: National Cancer Institute
  funderid: https://doi.org/10.13039/100000054
– fundername: CIHR
– fundername: Intramural NIH HHS
  grantid: ZIA DK075013
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
1B1
1CY
1P~
1~5
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
AAEDT
AAEDW
AAFWJ
AAIKJ
AALRI
AAQFI
AAQOH
AAQQT
AAQXK
AAXUO
ABCQX
ABDPE
ABJNI
ABLJU
ABMAC
ABOCM
ABWVN
ACRPL
ACVFH
ADBBV
ADCNI
ADMUD
ADNMO
AENEX
AEVXI
AFFNX
AFHKK
AFJKZ
AFRHN
AFTJW
AGCQF
AGHFR
AGQPQ
AI.
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BELOY
BR6
C5W
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
F5P
FD8
FDB
FEDTE
FGOYB
GBLVA
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M41
MO0
N4W
N9A
NQ-
O9-
OC.
OHT
ON0
P2P
PC.
QTD
R2-
ROL
RPZ
SEL
SES
SJN
SSZ
UDS
UGJ
UV1
VH1
WH7
X7M
XH2
Y6R
YQJ
Z5R
ZGI
ZXP
AAIAV
AAYOK
ADPAM
AFCTW
AGZHU
AHPSJ
ALXNB
G8K
RIG
TWZ
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-e365t-986e48a7b891e6d47b2a01f0ca5970d2fce2306718f5fb6d0d17e0acc3c843d23
ISSN 0016-5085
1528-0012
IngestDate Sun Sep 28 09:05:41 EDT 2025
Mon Jul 21 05:45:55 EDT 2025
Fri Feb 23 02:39:54 EST 2024
Tue Aug 26 16:58:42 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords NAFLD
DNL
UPLC-QTOFMS
Lipidomics
CM
DAG
NASH
HOMA-IR
SD
GAN
VLDL
Diacylglycerols
TAG
Postprandial Lipids
Mixed Meal
BMI
Language English
License Published by Elsevier Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-e365t-986e48a7b891e6d47b2a01f0ca5970d2fce2306718f5fb6d0d17e0acc3c843d23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7549-8216
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/9117487
PMID 35283114
PQID 2638943502
PQPubID 23479
PageCount 14
ParticipantIDs proquest_miscellaneous_2638943502
pubmed_primary_35283114
elsevier_sciencedirect_doi_10_1053_j_gastro_2022_03_004
elsevier_clinicalkey_doi_10_1053_j_gastro_2022_03_004
PublicationCentury 2000
PublicationDate June 2022
2022-06-00
20220601
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: June 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Gastroenterology (New York, N.Y. 1943)
PublicationTitleAlternate Gastroenterology
PublicationYear 2022
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Berlanga, Guiu-Jurado, Porras (bib2) 2014; 7
Takyar, Nath, Beri (bib41) 2017; 66
Pirazzi, Adiels, Burza (bib26) 2012; 57
Barrows, Parks (bib31) 2006; 91
Lambert, Parks (bib6) 2012; 1821
Abulizi, Vatner, Ye (bib33) 2020; 61
Lambert, Ramos-Roman, Browning (bib32) 2014; 146
Hodson (bib17) 2019; 78
Heath, Karpe, Milne (bib12) 2007; 292
Mucinski, Manrique-Acevedo, Kasumov (bib20) 2020; 55
Rotman, Koh, Zmuda (bib24) 2010; 52
Sekizkardes, Chung, Chacko (bib34) 2020; 130
Sparks, Sparks, Adeli (bib13) 2012; 32
Choi, Ginsberg (bib14) 2011; 22
Musso, Cipolla, Cassader (bib23) 2017; 58
Liebisch, Fahy, Aoki (bib9) 2020; 61
Fabbrini, Mohammed, Magkos (bib15) 2008; 134
Smagris, Gilyard, BasuRay (bib18) 2016; 291
Moerman, Visscher, Slijkhuis (bib38) 2021; 62
Toledo, Wang, Ruiz-Canela (bib37) 2017; 106
Guerci, Verges, Durlach (bib5) 2000; 24
Dumas, Kinross, Nicholson (bib4) 2014; 146
Puri, Wiest, Cheung (bib11) 2009; 50
LaBarre, Singer, Burant (bib40) 2021; 151
Luukkonen, Nick, Holtta-Vuori (bib27) 2019; 4
Kozlitina, Smagris, Stender (bib22) 2014; 46
Younossi, Stepanova, Ong (bib1) 2019; 17
Jung, Lee, Puri (bib35) 2020; 52
Lalanne, Pruneta, Bernard (bib19) 1999; 29
Luukkonen, Qadri, Lehtimaki (bib25) 2021; 106
Adiels, Westerbacka, Soro-Paavonen (bib16) 2007; 50
Irshad, Chmel, Adya (bib21) 2019; 60
Kumashiro, Erion, Zhang (bib30) 2011; 108
Petersen, Shulman (bib28) 2017; 38
Naguib, Morris, Yang (bib8) 2020; 40
Magkos, Su, Bradley (bib29) 2012; 142
Paynter, Balasubramanian, Giulianini (bib36) 2018; 137
Cai, Zhang, Ji (bib39) 2020; 126
Puri, Baillie, Wiest (bib10) 2007; 46
Fan, Cao (bib3) 2013; 28
Heinrich, Kohler, Ellmann (bib7) 2018; 8
References_xml – volume: 106
  start-page: e300
  year: 2021
  end-page: e315
  ident: bib25
  article-title: The PNPLA3-I148M variant confers an antiatherogenic lipid profile in insulin-resistant patients
  publication-title: J Clin Endocrinol Metab
– volume: 29
  start-page: 139
  year: 1999
  end-page: 144
  ident: bib19
  article-title: Distribution of diacylglycerols among plasma lipoproteins in control subjects and in patients with non-insulin-dependent diabetes
  publication-title: Eur J Clin Invest
– volume: 130
  start-page: 3592
  year: 2020
  end-page: 3602
  ident: bib34
  article-title: Free fatty acid processing diverges in human pathologic insulin resistance conditions
  publication-title: J Clin Invest
– volume: 50
  start-page: 1827
  year: 2009
  end-page: 1838
  ident: bib11
  article-title: The plasma lipidomic signature of nonalcoholic steatohepatitis
  publication-title: Hepatology
– volume: 62
  year: 2021
  ident: bib38
  article-title: Lipid signature of advanced human carotid atherosclerosis assessed by mass spectrometry imaging
  publication-title: J Lipid Res
– volume: 46
  start-page: 1081
  year: 2007
  end-page: 1090
  ident: bib10
  article-title: A lipidomic analysis of nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 40
  start-page: 590
  year: 2020
  end-page: 597
  ident: bib8
  article-title: Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: a palmitate breath test study
  publication-title: Liver Int
– volume: 291
  start-page: 10659
  year: 2016
  end-page: 10676
  ident: bib18
  article-title: Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins
  publication-title: J Biol Chem
– volume: 7
  start-page: 221
  year: 2014
  end-page: 239
  ident: bib2
  article-title: Molecular pathways in non-alcoholic fatty liver disease
  publication-title: Clin Exp Gastroenterol
– volume: 52
  start-page: 1603
  year: 2020
  end-page: 1614
  ident: bib35
  article-title: Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease
  publication-title: Aliment Pharmacol Ther
– volume: 52
  start-page: 894
  year: 2010
  end-page: 903
  ident: bib24
  article-title: The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 106
  start-page: 973
  year: 2017
  end-page: 983
  ident: bib37
  article-title: Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet
  publication-title: Am J Clin Nutr
– volume: 60
  start-page: 111
  year: 2019
  end-page: 120
  ident: bib21
  article-title: Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2
  publication-title: J Lipid Res
– volume: 146
  start-page: 726
  year: 2014
  end-page: 735
  ident: bib32
  article-title: Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease
  publication-title: Gastroenterology
– volume: 151
  start-page: 2868
  year: 2021
  end-page: 2881
  ident: bib40
  article-title: Advantages of studying the metabolome in response to mixed-macronutrient challenges and suggestions for future research designs
  publication-title: J Nutr
– volume: 1821
  start-page: 721
  year: 2012
  end-page: 726
  ident: bib6
  article-title: Postprandial metabolism of meal triglyceride in humans
  publication-title: Biochim Biophys Acta
– volume: 22
  start-page: 353
  year: 2011
  end-page: 363
  ident: bib14
  article-title: Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
  publication-title: Trends Endocrinol Metab
– volume: 46
  start-page: 352
  year: 2014
  end-page: 356
  ident: bib22
  article-title: Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
  publication-title: Nat Genet
– volume: 61
  start-page: 1539
  year: 2020
  end-page: 1555
  ident: bib9
  article-title: Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures
  publication-title: J Lipid Res
– volume: 61
  start-page: 1565
  year: 2020
  end-page: 1576
  ident: bib33
  article-title: Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice
  publication-title: J Lipid Res
– volume: 126
  start-page: 679
  year: 2020
  end-page: 704
  ident: bib39
  article-title: Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases
  publication-title: Circ Res
– volume: 8
  year: 2018
  ident: bib7
  article-title: Correcting for natural isotope abundance and tracer impurity in MS-, MS/MS- and high-resolution-multiple-tracer-data from stable isotope labeling experiments with IsoCorrectoR
  publication-title: Sci Rep
– volume: 134
  start-page: 424
  year: 2008
  end-page: 431
  ident: bib15
  article-title: Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease
  publication-title: Gastroenterology
– volume: 55
  start-page: 387
  year: 2020
  end-page: 393
  ident: bib20
  article-title: Relationships between very low-density lipoproteins-ceramides, -diacylglycerols, and -triacylglycerols in insulin-resistant men
  publication-title: Lipids
– volume: 38
  start-page: 649
  year: 2017
  end-page: 665
  ident: bib28
  article-title: Roles of diacylglycerols and ceramides in hepatic insulin resistance
  publication-title: Trends Pharmacol Sci
– volume: 24
  start-page: 468
  year: 2000
  end-page: 478
  ident: bib5
  article-title: Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients
  publication-title: Int J Obes Relat Metab Disord
– volume: 57
  start-page: 1276
  year: 2012
  end-page: 1282
  ident: bib26
  article-title: Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
  publication-title: J Hepatol
– volume: 146
  start-page: 46
  year: 2014
  end-page: 62
  ident: bib4
  article-title: Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease
  publication-title: Gastroenterology
– volume: 142
  start-page: 1444
  year: 2012
  end-page: 1446.e2
  ident: bib29
  article-title: Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects
  publication-title: Gastroenterology
– volume: 4
  year: 2019
  ident: bib27
  article-title: Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids
  publication-title: JCI Insight
– volume: 58
  start-page: 1221
  year: 2017
  end-page: 1229
  ident: bib23
  article-title: TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD
  publication-title: J Lipid Res
– volume: 108
  start-page: 16381
  year: 2011
  end-page: 16385
  ident: bib30
  article-title: Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
  publication-title: Proc Natl Acad Sci U S A
– volume: 137
  start-page: 841
  year: 2018
  end-page: 853
  ident: bib36
  article-title: Metabolic predictors of incident coronary heart disease in women
  publication-title: Circulation
– volume: 292
  start-page: E732
  year: 2007
  end-page: E739
  ident: bib12
  article-title: Dietary fatty acids make a rapid and substantial contribution to VLDL-triacylglycerol in the fed state
  publication-title: Am J Physiol Endocrinol Metab
– volume: 66
  start-page: 825
  year: 2017
  end-page: 833
  ident: bib41
  article-title: How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool
  publication-title: Hepatology
– volume: 32
  start-page: 2104
  year: 2012
  end-page: 2112
  ident: bib13
  article-title: Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 78
  start-page: 126
  year: 2019
  end-page: 134
  ident: bib17
  article-title: Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state
  publication-title: Proc Nutr Soc
– volume: 17
  start-page: 748
  year: 2019
  end-page: 755.e3
  ident: bib1
  article-title: Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates
  publication-title: Clin Gastroenterol Hepatol
– volume: 91
  start-page: 1446
  year: 2006
  end-page: 1452
  ident: bib31
  article-title: Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states
  publication-title: J Clin Endocrinol Metab
– volume: 28
  start-page: 81
  year: 2013
  end-page: 87
  ident: bib3
  article-title: Role of diet and nutritional management in non-alcoholic fatty liver disease
  publication-title: J Gastroenterol Hepatol
– volume: 50
  start-page: 2356
  year: 2007
  end-page: 2365
  ident: bib16
  article-title: Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance
  publication-title: Diabetologia
SSID ssj0009381
Score 2.489365
Snippet Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the...
SourceID proquest
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 1990
SubjectTerms Animals
Diacylglycerols
Diglycerides - metabolism
Humans
Insulins - metabolism
Lipidomics
Liver - metabolism
Mice
Mixed Meal
NAFLD
Non-alcoholic Fatty Liver Disease - metabolism
Postprandial Lipids
Prospective Studies
Title Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0016508522002359
https://dx.doi.org/10.1053/j.gastro.2022.03.004
https://www.ncbi.nlm.nih.gov/pubmed/35283114
https://www.proquest.com/docview/2638943502
Volume 162
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1528-0012
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009381
  issn: 0016-5085
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5cB0ovpe-4L7bQm5ErrV7rY5o2MSEJgSYhPYnVPoJbVwqybEhO_Vf9e519SLKDC2kuwgjWHjSfd78ZfTOD0EeeqpipVHg8CYkXpcz3mApzL6ZKJHksBBE6NXB0nEzOooOL-KLX-7OiWlrU-YjfbKwruY9X4R74VVfJ_odn2y-FG_AZ_AtX8DBc7-RjPWn3qtKFKfCgT4AH_2JDPYxa6FJjXQCy1G2DzYh5NeXDnZlpoewo4kRqMTX3BFi6BNr5Zcr49exyds1lVc6MTPZY03QzQhdW77EaCPuh1nHonp3tax3HbPfZvK5K3eGzsm2dNoz5GQbjaDWze67PvHI-7ZRKw4NRmyCQhfed_SyXJnXfKUFOSjG_WRSu0EgWw912yURWfFE0Zd8O9y6lAdFwK72yebam1mZNCqrJqQd0Ml7buxOyAtJ0ZScOxnYMqTvVtQZv44nhm7EfP0aX5imNtDm2623UnZCtbvGbNkLbQIhpFDR-gLZImiSkj7b2Px-e73T9nkNqhzU6o5uqzTj8tOm31qjQv0IdQ3lOn6DHLlbBOxZ4T1FPFs_QwyOnxniOfq_iD1v84Q5_2OIPN_jDHf5wqfAt_OFb-MPTAq_iDxv8YYM_7PD3Ap3tfT3dnXhuoocnwySuvTFNZERZmtNxIBMRpTlhfqB8ziCu9QVRXOqQGPiSilWeCF8EqfQZ5yGnUShI-BL1i7KQ2wiHPuwkEHMlStBI0pxKQqjiCgiqUpTQAYqbJ5o1RcZwLGbg98wIL-IQAl_riUx7IvPDDDwxQGm7zpFQSy7vsPJD47gM9mj94o0VslzMM6LDAohLfDJAr6xHsyvbTCYz3ZWCIHp9T3vfoEfdX-gt6tfVQr4Dnlzn7x0m_wI3xcKN
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Postprandial+Plasma+Lipidomics+Reveal+Specific+Alteration+of+Hepatic-derived+Diacylglycerols+in+Nonalcoholic+Fatty+Liver+Disease&rft.jtitle=Gastroenterology+%28New+York%2C+N.Y.+1943%29&rft.au=Velenosi%2C+Thomas+J.&rft.au=Ben-Yakov%2C+Gil&rft.au=Podszun%2C+Maren+C.&rft.au=Hercun%2C+Julian&rft.date=2022-06-01&rft.pub=Elsevier+Inc&rft.issn=0016-5085&rft.volume=162&rft.issue=7&rft.spage=1990&rft.epage=2003&rft_id=info:doi/10.1053%2Fj.gastro.2022.03.004&rft.externalDocID=S0016508522002359
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0016-5085&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0016-5085&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0016-5085&client=summon